Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
A-kinase anchoring protein 17B, pseudogene (AKAP17BP), is annotated as a pseudogene, a type of genomic DNA that resembles a functional gene but generally lacks protein-coding capacity and biological activity. Unlike bona fide A-kinase anchoring proteins (AKAPs), which serve as scaffold proteins organizing signaling complexes around protein kinase A[2][3][4][5], there is no evidence that AKAP17BP produces a functional protein or is implicated in any biological function, disease, or therapeutic context. AKAPs as a family are important scaffolds organizing protein kinase A signaling, but only genes encoding real, functional AKAP proteins are plausible drug targets[3][5]. Pseudogenes like AKAP17BP are not generally studied as therapeutic targets, biomarkers, or have clinical utility. If you intended information on a functional AKAP (such as AKAP17A or AKAP17B, if such protein-coding genes exist), please clarify the gene or target designation. Otherwise, AKAP17BP is not a therapeutic target.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on A-kinase anchoring protein 17B, pseudogene (AKAP17BP).